Latest News

 Filter by Provider

CVLT combines strong revenue growth and profitability with a technical setup suggesting a potential momentum shift, offering a strategic entry point.

Being aware of these changes can help you avoid unnecessary penalties.

November ADP data allows us to guesstimate nonfarm payroll employment, while the Fed’s data for industrial and manufacturing production in September gives us more of a reading on September.

Academic publishing company John Wiley & Sons (NYSE:WLY) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 1.1% year on year to $421.8 million. Its non-GAAP profit of $1.10 per share was 13.4% above analysts’ consensus estimates.

The metal market is looking for direction, and both Gold and Silver are poised to retest their recent peaks.

The Tel Aviv, Israel-based company said this agreement is expected to deliver “meaningful” six-figure revenue with a strong growth potential.

Once one of the market's hottest stocks, Peloton is now a poster child for stock market struggles.

PayPal has been in a slump going back to 2021.

Dollar General raised its financial outlook for fiscal 2025 after posting a 4.6% increase in revenue and a 44% surge in net income for the third quarter.

Interparfums (IPAR) fits Peter Lynch's GARP strategy with strong earnings growth, high profitability, minimal debt, and an attractive valuation.

Hormel Foods reports mixed Q4 results with an EPS beat and revenue miss. Shares surge 7% pre-market as the company outlines a clear path for profitable growth in Fiscal 2026.

Used-car retailer America’s Car-Mart (NASDAQ:CRMT) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 1.2% year on year to $350.2 million. Its GAAP loss of $2.71 per share was significantly below analysts’ consensus estimates.

Uber leverages partnerships to expand fast, while Tesla’s end-to-end FSD stack bets on total control. The market will reward whichever model delivers sustainable safety and economics first.

ZenaTech announced its intention to acquire an established Australian surveying firm to enter the APAC market and expand its Drone as a Service platform.

Micron Technologies and Taiwan Semiconductor should be on your investment radar this month.

Crescent Biopharma announced a strategic partnership with the Chinese firm Sichuan Kelun-Biotech Biopharmaceutical Co. to fast-track its global oncology pipeline.

UP Fintech posted a 73.3% growth in Q3 revenue to a record $175.2 million, while net income jumped nearly threefold to a record $57 million.

Bunge Global SA (BG) presents a strong technical breakout setup with high momentum and a bullish flag pattern, signaling a potential upward move.

Donaldson Co. beats Q1 earnings estimates and raises its full-year profit outlook, driven by strong margin performance and growth in key segments.

If the AI data center boom continues, Vertiv may remain one of the hottest names in the space heading into 2026.

Gold holds steady around $4,200 as traders stay cautious ahead of next week’s Federal Reserve policy meeting.

The company stated that Aron remains in charge of his duties as the Chairman, President, and CEO of AMC Entertainment.

From artificial intelligence to cloud computing and consumer electronics, the “Magnificent Seven” sit at the center of some of the world’s most powerful industries.

Salesforce rival SAP logs a growth ranking jump to the 90th percentile amid its EU AI Cloud launch and robust Q3 cloud revenue results.

Corteva has underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

Magna International (MGA) shows a strong technical breakout setup with high trend and quality ratings, indicating a potential move from its current consolidation.

Nvidia's stock has sold off over the past month, but its long-term story remains intact.

Yum! Brands has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.

Government IT services provider Science Applications International Corporation (NASDAQ:SAIC) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.6% year on year to $1.87 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $7.3 billion at the midpoint. Its non-GAAP profit of $2.58 per share was 20.2% above analysts’ consensus estimates.

SPS Commerce (SPSC) shows strong fundamentals and a tightening technical setup, suggesting a potential breakout for growth investors.

The EUR/USD forecast remains bullish as the dollar weakened further following the release of dismal ADP and Services PMI data.

Check these off your list before taking the plunge.

Footwear, apparel, and accessories retailer Genesco (NYSE:GCO) met Wall Streets revenue expectations in Q3 CY2025, with sales up 3.3% year on year to $616.2 million. Its non-GAAP profit of $0.79 per share was 8.1% below analysts’ consensus estimates.

Wall Street bullish on Alphabet's TPU chips as potential major revenue driver, with analysts estimating a trillion-dollar market opportunity.

Semiconductor company Qualcomm could become a key player in the global artificial intelligence market.

According to a Reuters report, EU antitrust chief Teresa Ribera said the European Commission is evaluating whether to impose interim restrictions on Meta’s AI-enabled WhatsApp rollout.

Discount retailer Dollar General (NYSE:DG) met Wall Streets revenue expectations in Q3 CY2025, with sales up 4.6% year on year to $10.65 billion. Its GAAP profit of $1.28 per share was 37.6% above analysts’ consensus estimates.

Deckers Outdoor (DECK) exemplifies quality investing with strong brands, exceptional ROIC, zero debt, and high cash flow conversion.

For Jimmy Smith, the words always came easily. His dream of becoming a basketball star didn't pan out, but he upped his game in advertising.

With markets looking very bullish it’s a good time to check in on our Naked Put Screener, with Snowflake a stand out.

Axogen’s Avance is an acellular nerve scaffold for the treatment of adult and pediatric patients aged a month or older with sensory, mixed, and motor peripheral nerve discontinuities.